FDA Inspection 1022742 — Codel International Co., Ltd.

Codel International Co., Ltd. — FEI 3012269530

The FDA completed an inspection of Codel International Co., Ltd. on August 25, 2017 in Gangnam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 25, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gangnam (Korea (the Republic of))

Citations

IDCFRDescription
107921 CFR 211.22(a)Contract drug products--lack of responsibility
110521 CFR 211.22(d)Procedures not in writing, fully followed
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
187921 CFR 211.180(c)Records not made readily available to FDA
194221 CFR 211.180(e)Records reviewed annually
434221 CFR 211.142(b)Storage under appropriate conditions
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.